Dr. Khaled Benkali joined Certara in February 2020 as Clinical Pharmacology director, he brings strong business acumen and strategic perspective acquired through an executive MBA, a wealth of experience in Clinical Pharmacology gained in the pharmaceutical industry during 10 years (Galderma and Pierre Fabre, successively), and extensive exposure to in-licensing opportunities and interactions with regulatory bodies.

Prior to joining the industry, he was initially trained as a pharmacist at the University of Algiers, Algeria, and completed his training with a PhD in pharmacology and pharmacometrics at the University of Limoges, France, working with immunosuppressant drugs, and a post-doc focusing on the individualization of tacrolimus therapy using Nonmem. Dr Benkali masters gap analyses, due diligences and regulatory interactions.